Literature DB >> 11823981

Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas.

Tadashi Hasegawa1, Seiichiro Yamamoto, Takayuki Nojima, Takanori Hirose, Takashi Nikaido, Katsushige Yamashiro, Yoshihiro Matsuno.   

Abstract

Soft-tissue sarcomas in adults show great variations in histologic type and grade. A valid and reproducible prognostication system is needed to select patients with soft-tissue sarcomas who could benefit from adjuvant chemotherapy. This study was conducted to assess the validity and reproducibility of diagnosis of the histologic type, MIB-1 grade, and mitosis grade, as well as of the 3 components of these grading systems. MIB-1 grade is a recently proposed grading system for predicting the prognosis of patients with adult soft-tissue sarcomas on the basis of 3 criteria (tumor differentiation, necrosis, and MIB-1 score) and replaces the mitotic count in the French system with MIB-1 immunohistochemical staining. Four surgical pathologists from 4 institutions who had experience in diagnostic soft-tissue tumor pathology reviewed 130 cases of soft-tissue sarcoma and independently determined histologic type and grade. The validity of histologic diagnosis was measured by sensitivity and specificity, and that of grading was measured by kappa statistics and percentage agreement with the diagnosis of the expert panel at the National Cancer Center, which was defined as a gold standard. Interobserver reproducibility was measured by kappa and by percentage agreement between the diagnoses of the 4 pathologists. The validity of the diagnosis of histologic type was high for synovial sarcoma, small round-cell sarcoma, and liposarcoma (sensitivity 89% to 100%; specificity, 98% to 100%) but low for malignant fibrous histiocytoma (MFH) and spindle-cell sarcoma (73% to 75%; 93% to 95%). For the grading, the validity of the MIB-1 grade was substantial (kappa = 0.68; agreement, 79%) and higher than that of the mitosis grade (0.54; 69%). The most valid component was tumor differentiation (kappa = 0.79), followed by tumor necrosis (0.66), MIB-1 score (0.59), and mitotic score (0.37). Interobserver reproducibility of histologic diagnosis was high for small round-cell sarcoma, synovial sarcoma, and liposarcoma (kappa = 0.92, 0.90, 0.87; percentage agreement = 99%, 97%, 96%, respectively); for grading, reproducibility was highest for tumor differentiation (0.78; 87%) and second highest for MIB-1 grade (0.68; 79%). We conclude that diagnosis of the type of soft-tissue sarcoma for synovial sarcoma, small round-cell sarcoma, and liposarcoma and the MIB-1 grading system based on tumor differentiation are highly valid and reproducible among Japanese pathologists who are familiar with the grading system, whereas re-evaluation of histologic criteria is essential for other histologic types such as MFH and spindle-cell sarcoma. Copyright 2002 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823981     DOI: 10.1053/hupa.2002.30184

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  25 in total

1.  Diagnosis of primary esophageal synovial sarcoma by demonstration of t(X;18) translocation: a case report.

Authors:  Catherine Butori; Véronique Hofman; Rita Attias; Jerôme Mouroux; Florence Pedeutour; Paul Hofman
Journal:  Virchows Arch       Date:  2006-06-21       Impact factor: 4.064

2.  Soft tissue sarcoma with metastasis to the stomach: a case report.

Authors:  Lemuel Leon Dent; Cesar Yamil Cardona; Michael Clause Buchholz; Roosevelt Peebles; Julie Denise Scott; Derrick Jerome Beech; Billy Ray Ballard
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

3.  What is better/reliable, mitosis counting or Ki67/MIB1 staining?

Authors:  Mark Kriegsmann; Arne Warth
Journal:  Transl Lung Cancer Res       Date:  2016-10

4.  Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Authors:  Jeremy V Camp; Ulas Bagci; Yong-Kyu Chu; Brendan Squier; Mostafa Fraig; Silvia M Uriarte; Haixun Guo; Daniel J Mollura; Colleen B Jonsson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.

Authors:  Arnaud Uguen; Gwenaël Conq; Laurent Doucet; Matthieu Talagas; Sebastian Costa; Marc De Braekeleer; Pascale Marcorelles
Journal:  Virchows Arch       Date:  2015-04-01       Impact factor: 4.064

6.  Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.

Authors:  Ukihide Tateishi; Umio Yamaguchi; Kunihiko Seki; Takashi Terauchi; Yasuaki Arai; Tadashi Hasegawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-28       Impact factor: 9.236

7.  Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

Authors:  Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

8.  Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma.

Authors:  U Tateishi; T Hasegawa; Y Beppu; A Kawai; N Moriyama
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

9.  Expression of smooth muscle markers in so called malignant fibrous histiocytomas.

Authors:  T Hasegawa; F Hasegawa; T Hirose; T Sano; Y Matsuno
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

10.  [Importance of specialized centers in diagnosis and treatment of extremity-soft tissue sarcomas. Review of 603 cases].

Authors:  M Lehnhardt; A Daigeler; H H Homann; J Hauser; S Langer; L Steinsträsser; C Soimaru; A Puls; H U Steinau
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.